Seplat Energy's CEO Roger Brown hosts London Capital Markets Day and focuses the strategy. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

IP Group investee Apollo Therapeutics completes USD145 million raise

Thu, 17th Jun 2021 09:48

(Alliance News) - IP Group PLC on Thursday said its portfolio company Apollo Therapeutics Fund completed a USD145 million financing to further its pharmaceutical pipeline.

The London-based intellectual property businesses holds a minority stake in Apollo, which was added to its portfolio when it acquired Touchstone Innovations PLC. The recent financing leaves IP Group with an undiluted beneficial holding in Apollo of approximately 2%, currently valued at GBP3.5 million.

Apollo is a biopharmaceutical company founded in 2015 as a joint venture between AstraZeneca PLC, GlaxoSmithKline PLC and Johnson & Johnson, alongside the technology transfer offices of the University of Cambridge, University College London and Imperial College London.

The company said that Apollo will use the financing funds to further its pipeline of therapeutic programmes, based on leading British academic research, and expand its operations. This includes establishing a presence around Boston, Massachusetts, well-known for its higher education institutions.

IP Group noted that the raise was led by Patient Square Capital, which will take a controlling stake in the business. Investors including Rock Springs Capital, Reimagined Ventures and UCL Technology Fund also participated.

IP Group shares were trading down 1.4% at 115.20 pence each in London on Thursday morning.

By Scarlett Butler; scarlettbutler@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News

BROKER RATINGS: Credit Suisse raises Next; Barclays lifts Croda

BROKER RATINGS: Credit Suisse raises Next; Barclays lifts Croda

Today 09:50

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

29 Jul 21 22:08

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

29 Jul 21 16:00

AstraZeneca boss not yet sure if booster shots will be needed

(Sharecast News) - AstraZeneca does not know yet whether so-called 'booster' shots of its Covid-19 vaccine will be needed or not.

29 Jul 21 14:48

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.